These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30779602)

  • 1. Approaches for CNS delivery of drugs - nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment.
    Gupta S; Kesarla R; Omri A
    Expert Opin Drug Deliv; 2019 Mar; 16(3):287-300. PubMed ID: 30779602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in brain targeting and drug delivery of anti-HIV therapeutic agents.
    Al-Ghananeem AM; Smith M; Coronel ML; Tran H
    Expert Opin Drug Deliv; 2013 Jul; 10(7):973-85. PubMed ID: 23510097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
    Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
    Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting anti-HIV drugs to the CNS.
    Rao KS; Ghorpade A; Labhasetwar V
    Expert Opin Drug Deliv; 2009 Aug; 6(8):771-84. PubMed ID: 19566446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier and neuro-AIDS.
    Zhang YL; Ouyang YB; Liu LG; Chen DX
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4927-39. PubMed ID: 26744885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
    Pardeshi CV; Belgamwar VS
    Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS.
    Hanson LR; Frey WH
    J Neuroimmune Pharmacol; 2007 Mar; 2(1):81-6. PubMed ID: 18040829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.
    DeMarino C; Schwab A; Pleet M; Mathiesen A; Friedman J; El-Hage N; Kashanchi F
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):31-50. PubMed ID: 27372507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art.
    Fiandra L; Capetti A; Sorrentino L; Corsi F
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):17-30. PubMed ID: 27832401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain.
    Wong HL; Chattopadhyay N; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):503-17. PubMed ID: 19914319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directing the Antiretroviral Drugs to the Brain Reservoir: A Nanoformulation Approach for NeuroAIDS.
    Nabi B; Rehman S; Pottoo FH; Baboota S; Ali J
    Curr Drug Metab; 2021; 22(4):280-286. PubMed ID: 32964821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment.
    Nelson AG; Zhang X; Ganapathi U; Szekely Z; Flexner CW; Owen A; Sinko PJ
    J Control Release; 2015 Dec; 219():669-680. PubMed ID: 26315816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
    Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
    Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.
    Varghese NM; Senthil V; Saxena SK
    J Drug Target; 2018 Mar; 26(3):195-207. PubMed ID: 28866957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites.
    Vyas TK; Shah L; Amiji MM
    Expert Opin Drug Deliv; 2006 Sep; 3(5):613-28. PubMed ID: 16948557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies.
    Du L; Chen L; Liu F; Wang W; Huang H
    Int Rev Neurobiol; 2023; 171():255-297. PubMed ID: 37783558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-ART and NeuroAIDS.
    Das MK; Sarma A; Chakraborty T
    Drug Deliv Transl Res; 2016 Oct; 6(5):452-72. PubMed ID: 27137528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose-Brain Drug Delivery.
    Taha E; Shetta A; Nour SA; Naguib MJ; Mamdouh W
    Mol Pharm; 2024 Mar; 21(3):999-1014. PubMed ID: 38329097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
    Islam SU; Shehzad A; Ahmed MB; Lee YS
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32326318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.